Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian M Ortmann

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
BMJ Oncology|January 31, 2025
Hypoxia-inducible factor in cancer: from pathway regulation to therapeutic opportunityBrian M Ortmann
The FEBS Journal|June 14, 2021
Genetic approaches to understand cellular responses to oxygen availabilityBrian M Ortmann, James A Nathan
Trends in Biochemical Sciences|April 10, 2024
Hypoxia research, where to now?Brian M Ortmann, Cormac T Taylor, Sonia Rocha
Nature Communications|August 15, 2020
ABHD11 maintains 2-oxoglutarate metabolism by preserving functional lipoylation of the 2-oxoglutarate dehydrogenase complexPeter S J Bailey, Brian M Ortmann, Anthony W Martinelli, et al.
Cell Reports|July 12, 2024
Hypoxia drives HIF2-dependent reversible macrophage cell cycle entryBo Meng, Na Zhao, Petra Mlcochova, et al.
Nature Communications|August 9, 2023
A HIF independent oxygen-sensitive pathway for controlling cholesterol synthesisAnna S Dickson, Tekle Pauzaite, Esther Arnaiz, et al.
Nature Communications|November 27, 2023
Author Correction: A HIF independent oxygen-sensitive pathway for controlling cholesterol synthesisAnna S Dickson, Tekle Pauzaite, Esther Arnaiz, et al.
Nature Communications|March 27, 2024
Author Correction: A HIF independent oxygen-sensitive pathway for controlling cholesterol synthesisAnna S Dickson, Tekle Pauzaite, Esther Arnaiz, et al.
Nature Communications|March 13, 2026
VHL synthetic lethality screens uncover CBF-β as a negative regulator of STINGJames A C Bertlin, Tekle Pauzaite, Qian Liang, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2024
VHL synthetic lethality screens uncover CBF-β as a negative regulator of STINGJames A C Bertlin, Tekle Pauzaite, Qian Liang, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
BMJ Oncology|January 31, 2025
Hypoxia-inducible factor in cancer: from pathway regulation to therapeutic opportunityBrian M Ortmann
The FEBS Journal|June 14, 2021
Genetic approaches to understand cellular responses to oxygen availabilityBrian M Ortmann, James A Nathan
Trends in Biochemical Sciences|April 10, 2024
Hypoxia research, where to now?Brian M Ortmann, Cormac T Taylor, Sonia Rocha
Nature Communications|August 15, 2020
ABHD11 maintains 2-oxoglutarate metabolism by preserving functional lipoylation of the 2-oxoglutarate dehydrogenase complexPeter S J Bailey, Brian M Ortmann, Anthony W Martinelli, et al.
Cell Reports|July 12, 2024
Hypoxia drives HIF2-dependent reversible macrophage cell cycle entryBo Meng, Na Zhao, Petra Mlcochova, et al.
Nature Communications|August 9, 2023
A HIF independent oxygen-sensitive pathway for controlling cholesterol synthesisAnna S Dickson, Tekle Pauzaite, Esther Arnaiz, et al.
Nature Communications|November 27, 2023
Author Correction: A HIF independent oxygen-sensitive pathway for controlling cholesterol synthesisAnna S Dickson, Tekle Pauzaite, Esther Arnaiz, et al.
Nature Communications|March 27, 2024
Author Correction: A HIF independent oxygen-sensitive pathway for controlling cholesterol synthesisAnna S Dickson, Tekle Pauzaite, Esther Arnaiz, et al.
Nature Communications|March 13, 2026
VHL synthetic lethality screens uncover CBF-β as a negative regulator of STINGJames A C Bertlin, Tekle Pauzaite, Qian Liang, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2024
VHL synthetic lethality screens uncover CBF-β as a negative regulator of STINGJames A C Bertlin, Tekle Pauzaite, Qian Liang, et al.
Pageof 2